UBS AM
INSP icon

UBS AM’s Inspire Medical Systems INSP Stock Holding History

UBS AM’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4M Buy
546,020
+97,233
+22% +$4.61M ﹤0.01% 854
2026
Q1 		$23.1M Sell
448,787
-14,529
-3% -$1.02M ﹤0.01% 831
2025
Q4 		$42.7M Sell
463,316
-370,283
-44% -$35.4M 0.01% 643
2025
Q3 		$61.9M Buy
833,599
+225,291
+37% +$22.8M 0.01% 566
2025
Q2 		$78.9M Sell
608,308
-504,617
-45% -$73.2M 0.02% 585
2025
Q1 		$177M Buy
1,112,925
+759,090
+215% +$137M 0.05% 395
2024
Q4 		$65.6M Sell
353,835
-11,333
-3% -$2.2M 0.02% 608
2024
Q3 		$77.1M Sell
365,168
-201,508
-36% -$35M 0.02% 579
2024
Q2 		$75.8M Buy
566,676
+519,567
+1,103% +$98.3M 0.02% 519
2024
Q1 		$10.1M Sell
47,109
-55,847
-54% -$10.9M ﹤0.01% 987
2023
Q4 		$20.9M Sell
102,956
-334
-0.3% -$54.1K 0.01% 756
2023
Q3 		$20.5M Buy
103,290
+14,775
+17% +$3.73M 0.01% 756
2023
Q2 		$20.7M Hold
88,515
– – 0.01% 756
2023
Q1 		$20.7M Sell
88,515
-2,369
-3% -$599K 0.01% 756
2022
Q4 		$22.9M Buy
90,884
+8,057
+10% +$1.72M 0.01% 720
2022
Q3 		$14.7M Sell
82,827
-13,697
-14% -$2.75M 0.01% 842
2022
Q2 		$17.6M Sell
96,524
-3,376
-3% -$673K 0.01% 770
2022
Q1 		$25.6M Sell
99,900
-2,261
-2% -$517K 0.01% 774
2021
Q4 		$23.5M Sell
102,161
-2,017
-2% -$492K 0.01% 863
2021
Q3 		$24.3M Sell
104,178
-555
-0.5% -$116K 0.01% 819
2021
Q2 		$20.2M Sell
104,733
-3,426
-3% -$679K 0.01% 883
2021
Q1 		$22.4M Sell
108,159
-28,883
-21% -$6.14M 0.01% 829
2020
Q4 		$25.8M Sell
137,042
-48,520
-26% -$7.93M 0.01% 777
2020
Q3 		$23.9M Buy
185,562
+5,993
+3% +$660K 0.01% 718
2020
Q2 		$15.6M Buy
179,569
+170,563
+1,894% +$13.1M 0.01% 803
2020
Q1 		$543K Sell
9,006
-162
-2% -$12K ﹤0.01% 1946
2019
Q4 		$680K Buy
9,168
+5,644
+160% +$363K ﹤0.01% 2105
2019
Q3 		$215K Buy
+3,524
New +$232K ﹤0.01% 2557

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS AM's INSP Position: Q2 2026 in Review

UBS AM increased its Inspire Medical Systems (INSP) stake by 22% in Q2 2026, buying an estimated $4.61M and bringing the position to 546,020 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #854.

UBS AM first reported a position in INSP in Q3 2019 and has held it in 28 quarters since. The position peaked at $177M in Q1 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • UBS AM held 546,020 shares of Inspire Medical Systems worth $24.4M as of Q2 2026.
  • UBS AM bought 97,233 Inspire Medical Systems shares in Q2 2026, an estimated $4.61M.
  • Inspire Medical Systems made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #854 holding.
  • UBS AM first reported a position in Inspire Medical Systems in Q3 2019 and has held it in 28 quarters since.
  • UBS AM's Inspire Medical Systems position peaked at $177M in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.